MedTrace Logo

Atara Biotherapeutics, Inc.

Company

Also known as: Atara, Atara Biotherapeutics Inc, Atara Biotherapeutics Inc.

Company Profile

Atara Biotherapeutics is a biotechnology company developing therapies for cancer and autoimmune diseases, with a focus on allogeneic T-cell immunotherapy platforms. The company was incorporated in 2012, is headquartered in Thousand Oaks, California, and is listed on Nasdaq under ATRA.

Headquarters
Thousand Oaks, California, United States
Founded
2012
Stock Ticker
NASDAQ:ATRA

Related News

Class Action Lawsuits Filed Against Atara, Ultragenyx, Mereo, and Vistagen Over Alleged Misstatements

Class action lawsuits allege false statements about clinical trial results and regulatory prospects at Atara Biotherapeutics, Ultragenyx, Mereo BioPharma, and Vistagen Therapeutics. The complaints cite failed Phase 3 studies for setrusumab in Osteogenesis Imperfecta and fasedienol for social anxiety disorder, along with manufacturing issues affecting Atara's tabelecleucel application. Investors have deadlines ranging from April to May 2026 to seek lead plaintiff status.